MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

E-ISSN： 1873-5592|7|7|813-821

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.7, 2006-07, pp. : 813-821

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines

By Meesungnoen Jintana Jay-Gerin Jean-Paul Mankhetkorn Samlee

Canadian Journal of Physiology and Pharmacology, Vol. 80, Iss. 11, 2002-11 ,pp. : 1054-1063

NRC Research Press

Access to resources Recommend Favorite

MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion

By Lööscher Wolfgang Delanty Norman

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 711-713

Future Medicine

Access to resources Recommend Favorite

Effects of 12 Ca 2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression

By Takara K. Sakaeda T. Tanigawara Y. Nishiguchi K. Ohmoto N. Horinouchi M. Komada F. Ohnishi N. Yokoyama T. Okumura K.

European Journal of Pharmaceutical Sciences, Vol. 16, Iss. 3, 2002-08 ,pp. : 159-165

Elsevier

Access to resources Recommend Favorite

Genuine Functions of P-Glycoprotein (ABCB1)

Current Drug Metabolism, Vol. 9, Iss. 2, 2008-02 ,pp. : 167-174

Bentham Science Publishers

Access to resources Recommend Favorite

P-Glycoprotein Mediated Multidrug Resistance Reversal by Phytochemicals: A Review of SARFuture Perspective for Drug Design

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 22, 2016-06 ,pp. : 2484-2508

Bentham Science Publishers

Access to resources Recommend Favorite